Echo Therapeutics may raise $20 million through at-the-market offering

Company reports equity offering through MLV in prospectus supplement

By Devika Patel

Knoxville, Tenn., May 10 - Echo Therapeutics, Inc. arranged a $20 million at-the-market issuance sales agreement with MLV & Co. LLC on May 9, according to a prospectus supplement filed Thursday with the Securities and Exchange Commission.

Proceeds will be used for general corporate purposes.

Philadelphia-based Echo Therapeutics is a dual platform-enabled specialty therapeutics and diagnostics company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.